Join
Live feed
·
INSIDERFilingvia Quantisnow
Soleno Therapeutics Inc. logo

CHIEF FINANCIAL OFFICER Mackaness James H sold $360,460 worth of shares (7,874 units at $45.78), decreasing direct ownership by 7% to 111,298 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SLNO· Soleno Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLNO (Soleno Therapeutics Inc.) and more on Quantisnow.